4 May 2023
- Click on the timestamp to jump to the topic you are interested in.
- 00:00:05 Opening remarks by Chairperson Dr Anita Sharma 00:00:50 Checkpoint: Evidence and practice interactive session 00:02:41 Faculty introductions (Prof Andrew Coats, Prof Roger Chen, Prof Carol Pollock) 00:04:44 Pharmacovigilance video 00:06:00 Case study: Case background (T2D, worsening kidney function, albuminuria, heart failure) 00:09:30 Guidance on how to manage this patient, dissecting the pathology of the kidney disease and what treatment to prioritize (Prof Carol Pollock) 00:19:20 Triggers for a nephrologist referral (Prof Carol Pollock) 00:19:56 Impact of diet on sodium/potassium load and intraglomerular pressure (Prof Carol Pollock) 00:21:03 Understanding the importance of evaluating eGFR and UACR 00:22:14 Diagnosing and initiating treatment for heart failure (Prof Andrew Coats) 00:29:43 Empowering the GP to be confident in the principles of heart failure management (Prof Andrew Coats, Prof Carol Pollock) 00:31:13 eGFR dip management with SGLT2 inhibitor initiation 00:32:30 T2D management and glycemic control (Prof Roger Chen) 00:40:30 Balancing blood glucose, diabetic kidney disease and heart failure management (Prof Roger Chen) 00:45:26 Relationship between eGFR drops and treatment dosage (Prof Carol Pollock) 00:48:00 Is there a role for lipid lowering and antiplatelet agents? (Prof Andrew Coats) 00:49:32 Managing polypharmacy (all) 00:53:07 Managing mycotic genital infections associated with SGLT2 inhibitors (Prof Roger Chen) 00:54:55 Key messages on management of this patient and improving outcomes (all) 1:00:48 Q&A: If a hypertensive, non-diabetic patient has proteinuria, can we start SGLT2 inhibitors with ACE inhibitors? (Prof Carol Pollock) 1:02:02 Q&A: A patient has the (diabetic) kidney disease, heart failure and diabetes. Who should be following up on this patient? (Prof Andrew Coats, Prof Carol Pollock) 1:04:36 Checkpoint: Evidence and practice interactive session 1:05:32 Closing
![Prof Andrew Coats](/sites/default/files/user_uploads/Andrew-Coats.jpg)
Prof Andrew Coats
Scientific Director and CEO, Heart Research Institute, Sydney, Australia
Prof Coats is a fully accredited Physician and Cardiologist in the United Kingdom and Australia with a clinical interest in Heart Failure. He is an academic leader and entrepreneur with three decades working in globally ranked top 50 Universities. He has published over 750 peer-reviewed full papers and has been President of Heart Failure Association.
![Dr Anita Sharma](/sites/default/files/user_uploads/Anita-Sharma.jpg)
Dr Anita Sharma
Practice Principal at Platinum Medical Centre; and Senior Lecturer, Primary Care Unit, University of Queensland
Dr Sharma is a member of the Education Committee, Royal College of General Practitioners (RACGP); co-author of the RACGP General Practice Management of type 2 diabetes handbook; and serves on the Editorial Board for Medicine Today. Dr Sharma’s professional interests include education of GP registrars, medical students and fellow GPs and development of education modules in Type 2 Diabetes, CKD, Heart Failure, Atrial Fibrillation, Diabetes, Osteoporosis, Obesity, Anaemia and medico-legal matters. Cardio-metabolic diseases are her greatest passion.
![Prof Carol Pollock](/sites/default/files/user_uploads/Carol-Pollock.png)
Prof Carol Pollock
Renal Physician at Royal North Shore Hospital, Sydney; and Professor of Medicine at University of Sydney.
Prof Pollock is an academic nephrologist with over 440 publications in basic research and clinical medicine and over 32,000 citations. In 2021 she was awarded an Officer in the Order of Australia (AO) for distinguished service to medical research, education and science, to nephrology, clinical practice and governance. This year, she is the recipient of the International Society of Nephrology Alfred Newton Richards award that recognises excellence in laboratory based research.
![Prof Roger Chen](/sites/default/files/user_uploads/Roger-Chen.jpg)
Prof Roger Chen
Senior Staff Specialist, Endocrinology Department, St Vincent’s Hospital Sydney; Visiting Scientist, The Garvan Institute of Medical Research.
Prof Chen is the Medical Lead in the Metabolic Clinic in Mental Health at St Vincent’s Hospital, a cross-disciplinary clinical service aiming to build bridges in mental and metabolic health. He holds academic appointments as Conjoint Professor in Medicine at the University of New South Wales and is Head of the Endocrinology Stream, The Rebecca Cooper Foundation. He is Editor-in-Chief, Endocrinology Today and Senior Editor of Endocrinology, Diabetes and Metabolism Case Reports